{"url_path":"/sec/bold/8-k/2026-06-17/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/0001193125-26-273544-index.html","accession_number":"0001193125-26-273544","cik":"0001782303","ticker":"BOLD","issuer_name":"Boundless Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1782303/0001193125-26-273544-index.html","primary_entity_key":"0001782303","primary_entity_name":"Boundless Bio, Inc."},"word_count":237,"has_tables":true,"body_markdown":"## Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nAt the annual meeting of stockholders of Boundless Bio, Inc. (the Company) held on June 15, 2026 (the Meeting), two proposals were voted upon by the Company’s stockholders. The proposals are described in detail in the Company’s definitive proxy statement for the Meeting filed with the U.S. Securities and Exchange Commission on April 28, 2026. Below is a brief description of, and the final results of the votes for, each proposal.\n\nProposal 1: Each of the director nominees was elected as a Class II director to hold office until the Company’s 2029 annual meeting of stockholders, and until their respective successor is duly elected and qualified, by the votes set forth below.\n\nNominee\n\nVotes For\n\nVotes Withheld\n\nBroker Non‑Votes\n\nJames Christensen, Ph.D.\n\n9,287,096\n\n512,585\n\n5,757,105\n\nJennifer Lew\n\n9,271,084\n\n528,597\n\n5,757,105\n\n \n\nProposal 2: The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 by the votes set forth below.\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nBroker Non-Votes\n\n15,376,973\n\n127,747\n\n52,066\n\n—\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nBOUNDLESS BIO, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 17, 2026\n\nBy:\n\n/s/ Jessica Oien\n\n \n\n \n\n \n\nName: Jessica Oien\nTitle: Chief Legal Officer and Corporate Secretary"}